Evome Medical Technologies Inc.
EVMT.V
TSX
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -389.35% | -7.27% | 12.43% | 21.25% | 70.61% |
| Total Depreciation and Amortization | -44.82% | 114.88% | 29.30% | 67.46% | 94.98% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 740.99% | 4.73% | -29.37% | -29.11% | -79.12% |
| Change in Net Operating Assets | 367.02% | 144.15% | 358.99% | 23.68% | -49.59% |
| Cash from Operations | 1,129.89% | 189.14% | -20.78% | 13.78% | 83.03% |
| Capital Expenditure | 95.51% | 81.21% | 82.21% | 73.58% | -264.91% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 100.00% | 74.67% | 74.67% | 77.30% | 78.59% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -177.24% |
| Cash from Investing | 98.84% | 75.76% | 76.88% | 77.89% | 71.13% |
| Total Debt Issued | -130.45% | -165.87% | -202.77% | -- | -60.54% |
| Total Debt Repaid | -538.20% | -171.63% | 97.06% | 83.87% | -310.38% |
| Issuance of Common Stock | -100.00% | -100.00% | -100.00% | -99.24% | -99.24% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | 2,283.10% |
| Cash from Financing | -88.38% | -737.56% | -37.69% | 0.21% | -151.76% |
| Foreign Exchange rate Adjustments | 341.31% | 7,157.80% | 2,656.04% | 645.60% | 65.76% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 105.25% | 71.44% | 58.80% | 85.85% | 12.70% |